Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension
2023; Lippincott Williams & Wilkins; Volume: 147; Issue: 24 Linguagem: Inglês
10.1161/circulationaha.122.061501
ISSN1524-4539
AutoresChristophe Guignabert, Laurent Savale, Athénaïs Boucly, Raphaël Thuillet, Ly Tu, Mina Ottaviani, Christopher J. Rhodes, Pascal de Groote, Grégoire Prévôt, Emmanuel Bergot, Arnaud Bourdin, Luke Howard, Élie Fadel, Antoine Beurnier, Anne Roche, Mitja Jevnikar, Xavier Jaïs, David Montani, Martin R. Wilkins, Olivier Sitbon, Marc Humbert,
Tópico(s)Pulmonary Hypertension Research and Treatments
ResumoActivins are novel therapeutic targets in pulmonary arterial hypertension (PAH). We therefore studied whether key members of the activin pathway could be used as PAH biomarkers.
Referência(s)